Page last updated: 2024-10-25

eflornithine and Orphan Diseases

eflornithine has been researched along with Orphan Diseases in 1 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Orphan Diseases: Rare diseases that have not been well studied.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rajasekaran, S1
Bupp, CP1
Leimanis-Laurens, M1
Shukla, A1
Russell, C1
Junewick, J1
Gleason, E1
VanSickle, EA1
Edgerly, Y1
Wittmann, BM1
Prokop, JW1
Bachmann, AS1

Other Studies

1 other study available for eflornithine and Orphan Diseases

ArticleYear
Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease.
    eLife, 2021, 07-20, Volume: 10

    Topics: Alopecia; Child, Preschool; Dicarboxylic Acid Transporters; Drug Repositioning; Eflornithine; Exome

2021